86.68 0.00 (0.00%)
After hours: 4:08PM EST
|Bid||85.90 x 100|
|Ask||86.91 x 100|
|Day's range||86.03 - 87.90|
|52-week range||73.59 - 89.72|
|PE ratio (TTM)||23.84|
|Earnings date||20 Feb 2018|
|Forward dividend & yield||1.84 (2.14%)|
|1y target est||91.23|
The competition for full-size pickup truck customers in the U.S. is heating up as Ram and Chevrolet roll out brawny-looking new models at the Motor City's auto show
More foreign companies were in Beijing’s crosshairs Friday after including regions like Tibet and Taiwan in a list of independent countries on their websites.
Chinese regulators rebuked fashion brand Zara, Delta Air Lines and medical device maker Medtronic on Friday for calling Taiwan a country on their websites in a fresh show of Beijing's acute sensitivity ...
China's aviation authority on Friday demanded an apology from Delta Air Lines for listing Taiwan and Tibet as countries on its website, while another government agency took aim at Inditex-owned fashion brand Zara and medical device maker Medtronic Plc for similar issues. The moves follow a regulator's decision on Thursday to suspend Marriott International Inc's Chinese website for a week to punish the world's biggest hotel chain for listing Tibet, Taiwan, Hong Kong and Macau as separate countries in a customer questionnaire.
Stryker's 52-Week High: Should You Expect Further Upside?SYK stock at 52-week high On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4. As of January 9, 2018, SYK stock is trading higher than its 50-day moving average of $155 as well as the 200-day moving average of $148.1. Stryker traded at a 52-week low of $117.6 on January 9, 2017. The company’s one-year stock return is ~35% as of January 9, 2018.
Shares fall by double-digits during a quiet month for the robotic surgery upstart. Is there something to worry about, or is the pullback just market noise?
Over the last 12 months, MDT stock has risen ~10.8%. On a year-to-date basis, MDT stock has registered a price rise of ~14.3%.
On December 12, 2017, Argus Research analyst John Eade upgraded Medtronic (MDT) stock from a “hold” to a “buy.” He has a price target of $95.00 per share on the stock.
On November 27, 2017, Medtronic (MDT) announced the launch of its new telehealth solutions as part of its contract with the United States Department of Veterans Affairs (or VA).
Medtronic (MDT) is set to make another tuck-in acquisition for expanding its Endoscopy business. MDT plans to acquire Crospon, an Irish endoscopic diagnostics player.